LEAP India and Molbio Diagnostics Gain SEBI Approval for Initial Public Offerings
LEAP India and Molbio Diagnostics have received SEBI approval for their initial public offerings.
LEAP India and Molbio Diagnostics have received SEBI approval for their initial public offerings.
Leap India Limited has filed a draft red herring prospectus (DRHP) to raise Rs 2,400 crore through an IPO.